Antibacterial effect of bovine lactoferrin against udder pathogens

Acta Veterinaria Scandinavica

Volumn 44, Issue 1-2, 2003, Pages 35-42

  Kutila, T ^a   Pyorala S ^a   Saloniemi, H ^a   Kaartinen, L ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL AGENCY FOR MEDICINES   (Finland)

Author keywords

Growth inhibition; Mastitis pathogens

Indexed keywords

LACTOFERRIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM ISOLATE; CATTLE DISEASE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; ESCHERICHIA COLI; GROWTH INHIBITION; KLEBSIELLA PNEUMONIAE; MILK; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATHOGENESIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STATISTICAL SIGNIFICANCE; TURBIDIMETRY; ANIMAL; BACTERIUM; CATTLE; DRUG EFFECT; FEMALE; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

BACTERIA (MICROORGANISMS); BOS TAURUS; BOVINAE; ESCHERICHIA COLI; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

ANIMALS; BACTERIA; CATTLE; FEMALE; LACTOFERRIN; MASTITIS, BOVINE; MICROBIAL SENSITIVITY TESTS;

EID: 0642309847     PISSN: 0044605X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Appelmelk BJ, Yun-qing A, Geerts M, Thijs BG, Boer HA, Maclaren DM, Graaff J, Nuijens JH: Lactoferrin is a lipid A-binding protein. Infect. Immun. 1994, 62, 2628-2632.
2. Arnold RR, Brewer M, Gauthier JJ: Bactericidal activity of human lactoferrin: sensitivity of a variety of micro-organisms. Infect. Immun. 1980, 28, 893-898.
3. Baggiolini M, DeDuve C, Masson PL, Heremans JF: Association of lactoferrin with specific granules in rabbit heterophil leucocytes. J. Exp. Med. 1970, 131, 559-570.
4. Bellamy W, Takase M, Yamauchi K, Wakabayshi H, Kawase K, Tomita M: Identification of the bactericidal domain of lactoferrin. Biochim. Biophys. Acta 1992, 1121, 130-136.
5. Bhimani RS, Vendrov Y, Furmanski P: Influence of lactoferrin feeding and injection against systemic staphylococcal infections in mice. J. Appl. Microb. 1999, 86, 135-144.
6. Dalmastri C, Valenti P, Vittoriosso P, Orsi N: Enhanced antimicrobial activity of lactoferrin by binding to the bacterial surface. Microb. 1988, 11, 225-230.
7. Diarra MS, Peticlerc D, Lacasse P: Effect of lactoferrin in combination with penicillin on the morphology and the physiology of Staphylococcus aureus isolated from bovine mastitis. J. Dairy Sci. 2002, 85, 1141-1149.
8. Dionysius DA, Grieve PA, Milne JM: Forms of lactoferrin: their antibacterial effect on enterotoxigenic Escherichia coli. J. Dairy Sci. 1993, 76, 2597-2606.
9. Ellison RT III, Giehl TJ, LaForse FM: Damage of outer membrane of enteric gram negative bacteria by lactoferrin and transferrin. Infect. Immun. 1988, 56, 2774-2781.
10. 2+. J. Gen. Microbiol. 1990, 136, 1437-1446.
11. Harmon RJ, Schanbacher FL, Ferguson LC, Smith KL: Changes in lactoferrin, immunoglubulin G, bovine serum albumin, and alpha lactalbumin during acute experimental and natural coliform mastitis of cows. Infect. Immun. 1976, 13, 533-542.
12. Isomäki R: Separation of whey antimicrobial proteins and development of bovine lactoferrin immunoassays. Licenciate thesis. University of Oulu, 1999, 89 p.
13. Kawai K, Hagiwara S, Anri A, Nagahata H: Lactoferrin concentration in milk of bovine clinical mastitis. Vet. Res. Commun. 1999, 23, 391-398.
14. Lohuis JACM, Hensen SM, Beers H: Effect of lactoferrin and cephapirin, alone and in combination on growth of E. coli strains from mastitis. 3rd Int. Mast. Sem. Proc. II 1995, 110-111.
15. Lonnerdal B, Iyer S: Lactoferrin: molecular structure and biological function. Ann. Rev. Nutr. 1995, 15, 93-110.
16. Maisi P, Mattila T, Sandholm M: Mastitis whey - a good medium for bacteria? Acta vet. Scand. 1984, 25, 297-308.
17. Masson PL, Heremans JF, Dive C: An iron-binding protein common to many external secretions. Clin. Chim. Acta 1966, 14, 735-739.
18. Masson PL, Heremans JF, Schonne E: Lactoferrin, an iron-binding protein in neutrophilic leucocytes. J. Exp. Med. 1969, 130, 643-658.
19. Nonnecke BJ, Smith KL: Inhibition of mastitic bacteria by bovine milk apo-lactoferrin evaluated by in vitro microassay of bacterial growth. J. Dairy Sci. 1984, 67, 606-613.
20. Oliver SP, Bushe T: Growth inhibition of Escherichia coli and Klebsiella pneumoniae during involution of the bovine mammary gland: relation to secretion composition. Am. J. Vet. Res. 1987, 48, 1669-1973.
21. Rainard P: Bacteriostatic activity of bovine milk lactoferrin against mastitic bacteria. Vet. Microb. 1986, 11, 387-392.
22. Reiter B, Oram JD: Bacterial inhibitors in milk and other biological fluids. Nature (Lond.) 1967, 216, 328-330.
23. Sanchez MS, Watts J: Enhancement of the activity of novobiocin against Escerichia coli by lactoferrin. J. Dairy Sci. 1999, 82, 494-499.
24. Schanbacher FL, Talhouk RS, Murray FA: Biology and origin of bioactive peptides in milk. Livestock Prod. Sci. 1997, 50, 105-123.
25. Weinberg ED: Iron and infection. Mikrob. Rev. 1978, 42, 45-66.
26. Welty FK, Smith KL, Schanbacher FL: Lactoferrin concentration during involution of the bovine mammary gland. J. Dairy Sci. 1976, 59, 224-231.
27. Zhang G-H, Mann DM, Tsai C-M: Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptide. Infect. Immun. 1999, 67, 1353-1358.